Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Nuclear Medicine and Biology
|
June 28, 2022
In vivo tracking of [<sup>89</sup>Zr]Zr-labeled engineered extracellular vesicles by PET reveals organ-specific biodistribution based upon the route of administration
Shil Patel, Karl F Schmidt, Mohammed Farhoud, et al.
Journal of Inflammation Research
|
December 2, 2024
Study on the Predictive Value of Renal Resistive Index Combined with β2-Microglobulin in Patients with Urosepsis Complicated with Acute Kidney Injury
Haopeng Li, Juan Zhou, Qinghua Wang, et al.
International Journal of Biological Sciences
|
April 30, 2025
VAV2 exists in extrachromosomal circular DNA and contributes Enzalutamide resistance of prostate cancer via stabilization of AR/ARv7
Qinghua Wang, Xin'an Wang, Hanchu Ye, et al.
International Journal of Biological Macromolecules
|
January 24, 2024
Glycolysis related lncRNA SNHG3 / miR-139-5p / PKM2 axis promotes castration-resistant prostate cancer (CRPC) development and enzalutamide resistance
Yicong Yao, Xi Chen, Xin'an Wang, et al.
Journal of Cancer
|
January 26, 2026
Cuproptosis-related gene PROK1 predicts the diagnosis and prognosis of prostate cancer based on multiple machine learning
Xin Qin, Qinghua Wang, Wei Jiang, et al.
Frontiers in Oncology
|
September 8, 2023
An immunogenic cell death-related classification predicts prognosis and response to immunotherapy in kidney renal clear cell carcinoma
Licheng Wang, Yaru Zhu, Zhen Ren, et al.
Plos One
|
August 28, 2014
Spontaneous genomic alterations in a chimeric model of colorectal cancer enable metastasis and guide effective combinatorial therapy
Yinghui Zhou, William M Rideout, Angela Bressel, et al.
Science Advances
|
February 18, 2022
Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity
Sushrut Kamerkar, Charan Leng, Olga Burenkova, et al.
Nature Biotechnology
|
December 22, 2009
Chimeric mouse tumor models reveal differences in pathway activation between ERBB family- and KRAS-dependent lung adenocarcinomas
Yinghui Zhou, William M Rideout, Tong Zi, et al.
Molecular Cancer Therapeutics
|
January 14, 2021
Exosome Surface Display of IL12 Results in Tumor-Retained Pharmacology with Superior Potency and Limited Systemic Exposure Compared with Recombinant IL12
Nuruddeen D Lewis, Chang Ling Sia, Katherine Kirwin, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Nuclear Medicine and Biology
|
June 28, 2022
In vivo tracking of [<sup>89</sup>Zr]Zr-labeled engineered extracellular vesicles by PET reveals organ-specific biodistribution based upon the route of administration
Shil Patel, Karl F Schmidt, Mohammed Farhoud, et al.
Journal of Inflammation Research
|
December 2, 2024
Study on the Predictive Value of Renal Resistive Index Combined with β2-Microglobulin in Patients with Urosepsis Complicated with Acute Kidney Injury
Haopeng Li, Juan Zhou, Qinghua Wang, et al.
International Journal of Biological Sciences
|
April 30, 2025
VAV2 exists in extrachromosomal circular DNA and contributes Enzalutamide resistance of prostate cancer via stabilization of AR/ARv7
Qinghua Wang, Xin'an Wang, Hanchu Ye, et al.
International Journal of Biological Macromolecules
|
January 24, 2024
Glycolysis related lncRNA SNHG3 / miR-139-5p / PKM2 axis promotes castration-resistant prostate cancer (CRPC) development and enzalutamide resistance
Yicong Yao, Xi Chen, Xin'an Wang, et al.
Journal of Cancer
|
January 26, 2026
Cuproptosis-related gene PROK1 predicts the diagnosis and prognosis of prostate cancer based on multiple machine learning
Xin Qin, Qinghua Wang, Wei Jiang, et al.
Frontiers in Oncology
|
September 8, 2023
An immunogenic cell death-related classification predicts prognosis and response to immunotherapy in kidney renal clear cell carcinoma
Licheng Wang, Yaru Zhu, Zhen Ren, et al.
Plos One
|
August 28, 2014
Spontaneous genomic alterations in a chimeric model of colorectal cancer enable metastasis and guide effective combinatorial therapy
Yinghui Zhou, William M Rideout, Angela Bressel, et al.
Science Advances
|
February 18, 2022
Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity
Sushrut Kamerkar, Charan Leng, Olga Burenkova, et al.
Nature Biotechnology
|
December 22, 2009
Chimeric mouse tumor models reveal differences in pathway activation between ERBB family- and KRAS-dependent lung adenocarcinomas
Yinghui Zhou, William M Rideout, Tong Zi, et al.
Molecular Cancer Therapeutics
|
January 14, 2021
Exosome Surface Display of IL12 Results in Tumor-Retained Pharmacology with Superior Potency and Limited Systemic Exposure Compared with Recombinant IL12
Nuruddeen D Lewis, Chang Ling Sia, Katherine Kirwin, et al.
Page
of 3